Registry of Toxic Effects of Chemical Substances (RTECS)
Benzenamine, 4,4'-methylenebis(2-chloro-
RTECS #
CY1050000CAS #
101-14-4; 29371-14-0; 51065-07-7; 78642-65-6Updated
September 201Molecular Weight
267.17Molecular Formula
C13H12Cl2N2Synonyms
3,3'-Dichlor-4,4'-diaminodiphenylmethan (German)3,3'-Dichloro-4,4'-diaminodifenilmetano (Italian)
3,3'-Dichloro-4,4'-diaminodiphenylmethane
4,4'-Diamino-3,3'-dichlorodiphenylmethane
4,4'-Methylene bis(2-chloroaniline)
4,4'-Methylene bis(2-chloroaniline) (ACGIH)
4,4'-Methylene(bis)-chloroaniline
4,4'-Methylenebis(2-chloroaniline)
4,4'-Methylenebis(o-chloroaniline)
4,4'-Methylenebis-2-chlorobenzenamine
4,4-Metilene-bis-O-cloroanilina (Italian)
Aniline, 4,4'-methylenebis(2-chloro-
Bis amine
Bis(3-chloro-4-aminophenyl)methane
Bis(4-amino-3-chlorophenyl)methane
Bis-amine A
Bisamine S
CL-Mda
Cuamine M
Cuamine MT
Curalin M
Curene 442
Cyanaset
Dacpm
Di(-4-amino-3-chlorophenyl)methane
Di-(4-amino-3-clorofenil)metano (Italian)
Diamet Kh
LD 813
MBOCA
Mboca
Methylene 4,4'-bis(o-chloroaniline)
Methylene-bis-orthochloroaniline
Millionate M
MOCA
p,p'-Methylenebis(alpha-chloroaniline)
p,p'-Methylenebis(o-chloroaniline)
Quodorole
RCRA waste number U158
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
DNA Damage | /Bacillus subtilis | 1 mg/disc | PMRSDJ 1,175,1981 |
DNA Damage | oral/mouse | 600 mg/kg | MUREAV 440,1,1999 |
DNA Damage | lung/rat | 31.2 µmol/L/20H | MUREAV 605,94,2006 |
DNA Damage | lung/human | 3.9 µmol/L/20H | MUREAV 605,94,2006 |
DNA Damage | oral/rat | 570 mg/kg | MUREAV 605,94,2006 |
DNA repair | /Escherichia coli | 500 mg/L | PMRSDJ 1,195,1981 |
gene conversion and mitotic recombination | /Saccharomyes cerevisiae | 100 mg/L | PMRSDJ 1,491,1981 |
micronucleus test | intraperitoneal/mouse | 6400 µg/kg | PMRSDJ 1,686,1981 |
micronucleus test | lung/hamster | 20 µmol/L/6H (-enzymatic activation step) | MUTAEX 26,709,2011 |
micronucleus test | lung/hamster | 78 µmol/L/24H (-enzymatic activation step) | MUTAEX 26,709,2011 |
micronucleus test | lung/hamster | 78 µmol/L/48H (-enzymatic activation step) | MUTAEX 26,709,2011 |
morphological transform | fibroblast/mouse | 10 µg/L | JJIND8 67,1303,1981 |
morphological transform | embryo/rat | 1 mg/L | JJIND8 67,1303,1981 |
morphological transform | embryo/hamster | 2500 µg/L | AETODY 1,241,1980 |
morphological transform | kidney/hamster | 80 µg/L | BJCAAI 37,873,1978 |
mutation in microorganisms | lymphocyte/mouse | 5 mg/L (+enzymatic activation step) | EMMUEG 12(Suppl 13),103,1988 |
mutation in microorganisms | /Salmonella typhimurium | 100 µg/plate (+enzymatic activation step) | PMRSDJ 1,261,1981 |
mutation in microorganisms | /Salmonella typhimurium | 33 µg/plate (-enzymatic activation step) | ENMUDM 5(Suppl 1),3,1983 |
mutation in microorganisms | /Escherichia coli | 100 µg/plate (+enzymatic activation step) | PMRSDJ 1,387,1981 |
mutation in microorganisms | /Salmonella typhimurium | 100 mg/L/72H (+enzymatic activation step) | MUREAV 558,181,2004 |
phage inhibition capacity | /Escherichia coli | 1 gm/L | PMRSDJ 1,224,1981 |
sex chromosome loss and nondisjunction | /Saccharomyes cerevisiae | 50 mg/L | PMRSDJ 1,468,1981 |
sister chromatid exchange | ovary/hamster | 500 µg/L | ENMUDM 7,1,1985 |
specific locus test | oral/Drosophila melanogaster | 5 mmol/L/48H-continuous | MUREAV 211,279,1988 |
Unscheduled DNA Synthesis | liver/rat | 10 µmol/L | MUREAV 204,683,1988 |
Unscheduled DNA Synthesis | liver/hamster | 10 µmol/L | TXAPA9 58,231,1981 |
Unscheduled DNA Synthesis | liver/mouse | 10 µmol/L | TXAPA9 58,231,1981 |
Unscheduled DNA Synthesis | liver/rabbit | 10 µmol/L | CNREA8 43,3120,1983 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | toxic dose: 27 gm/kg/79W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors Liver: Tumors | NATWAY 58,578,1971 |
oral/rat | toxic dose: 27 gm/kg/78W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Liver: Tumors | TXAPA9 31,159,1975 |
oral/rat | toxic dose: 11 gm/kg/2Y- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors | JEPTDQ 2(1),149,1978 |
oral/rat | toxic dose: 8100 mg/kg/77W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Endocrine: Tumors | JEPTDQ 2(1),149,1978 |
oral/rat | toxic dose: 16 gm/kg/77W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors | JEPTDQ 2(1),149,1978 |
oral/rat | toxic dose: 27 gm/kg/65W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors | JEPTDQ 2(1),149,1978 |
oral/rat | toxic dose: 34 gm/kg/80W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Liver: Tumors | TXAPA9 31,159,1975 |
oral/rat | toxic dose: 21 gm/kg/60W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors | TXAPA9 31,159,1975 |
oral/rat | toxic dose: 24 gm/kg/57W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Liver: Tumors | TXAPA9 31,159,1975 |
oral/rat | lowest published toxic dose: 4050 mg/kg/77W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors | JEPTDQ 2(1),149,1978 |
subcutaneous/rat | lowest published toxic dose: 25 gm/kg/89W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Lung, Thorax, or Respiration: Tumors Liver: Tumors | NATWAY 58,578,1971 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/mouse | lethal dose (50 percent kill): 64 mg/kg | PMRSDJ 1,682,1981 | |
oral/guinea pig | lethal dose (50 percent kill): 400 mg/kg | Olfaction: Other olfaction effects Behavioral: Ataxia Lung, Thorax, or Respiration: Cyanosis | GISAAA 55(6),86,1990 |
oral/mouse | lowest published toxic dose: 83 mg/kg | Blood: Methemoglobinemia- Carboxhemoglobinemia | HPV076 -,-,2005 |
oral/mouse | lethal dose (50 percent kill): 640 mg/kg | Olfaction: Other olfaction effects Behavioral: Ataxia Lung, Thorax, or Respiration: Cyanosis | GISAAA 55(6),86,1990 |
oral/rat | lethal dose (50 percent kill): 1140 mg/kg | HPV076 -,-,2005 | |
oral/rat | lethal dose (50 percent kill): 1140 mg/kg | Olfaction: Other olfaction effects Behavioral: Ataxia Lung, Thorax, or Respiration: Cyanosis | GISAAA 55(6),86,1990 |
skin/rabbit | lethal dose (50 percent kill): >5000 mg/kg | HPV076 -,-,2005 | |
subcutaneous/rat | lethal dose (50 percent kill): >5 gm/kg | NATWAY 58,578,1971 | |
unreported route/rat | lowest published lethal dose: 1 gm/kg | Behavioral: Muscle weakness Lung, Thorax, or Respiration: Cyanosis Kidney, Ureter, and Bladder: Urine volume increased | AIHAAP 32,802,1971 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | lowest published toxic dose: 300 mg/kg/3D- intermittent | Behavioral: Food intake (animal) Endocrine: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | WDZAEK 7,30,1993 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.01 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Suspected human carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 4,65,1974 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 57,271,1993 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMSUDL 7,246,1987 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 57,271,1993 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 2A | IMEMDT 57,271,1993 |
TOXICOLOGY REVIEW | AIHAAP 39,496,1978 | |
TOXICOLOGY REVIEW | TOLED5 134,39,2002 | |
TOXICOLOGY REVIEW | MUREAV 543,201,2003 | |
TOXICOLOGY REVIEW | FCTOD7 44,1699,2006 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | BCLPT* 96,131,2005 | |
TOXICOLOGY REVIEW | MUREAV 654,114,2008 | |
TOXICOLOGY REVIEW | HUTOX* -,649,1996 | |
TOXICOLOGY REVIEW | MUTAEX 23,271,2008 | |
TOXICOLOGY REVIEW | MUREAV 741,32,2012 |
Standards and Regulations
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO MOCA-air | 10H Carcinogen time-weighted average 0.003 mg/m3 (Sk) | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 83341; Number of Industries 1; Total Number of Facilities 4; Number of Occupations 1; Total Number of Employees Exposed 114 | |
National Occupational Hazard Survey 1974 | Hazard Code 83341; Number of Industries 15; Total Number of Facilities 376; Number of Occupations 13; Total Number of Employees Exposed 2094 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division